Geode Capital Management’s Achilles Therapeutics plc American Depositary Shares ACHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21,590
| Closed | -$24.6K | – | 4525 |
|
|
2024
Q4 | $24.6K | Hold |
21,590
| – | – | ﹤0.01% | 4363 |
|
|
2024
Q3 | $22K | Hold |
21,590
| – | – | ﹤0.01% | 4385 |
|
|
2024
Q2 | $17.6K | Hold |
21,590
| – | – | ﹤0.01% | 4474 |
|
|
2024
Q1 | $27K | Hold |
21,590
| – | – | ﹤0.01% | 4436 |
|
|
2023
Q4 | $19.2K | Hold |
21,590
| – | – | ﹤0.01% | 4523 |
|
|
2023
Q3 | $19.6K | Hold |
21,590
| – | – | ﹤0.01% | 4631 |
|
|
2023
Q2 | $20.4K | Hold |
21,590
| – | – | ﹤0.01% | 4653 |
|
|
2023
Q1 | $20.7K | Hold |
21,590
| – | – | ﹤0.01% | 4698 |
|
|
2022
Q4 | $19K | Hold |
21,590
| – | – | ﹤0.01% | 4777 |
|
|
2022
Q3 | $48K | Hold |
21,590
| – | – | ﹤0.01% | 4776 |
|
|
2022
Q2 | $54K | Hold |
21,590
| – | – | ﹤0.01% | 4760 |
|
|
2022
Q1 | $63K | Buy |
21,590
+3,999
| +23% | +$11.7K | ﹤0.01% | 4765 |
|
|
2021
Q4 | $88K | Hold |
17,591
| – | – | ﹤0.01% | 4761 |
|
|
2021
Q3 | $137K | Buy |
+17,591
| New | +$137K | ﹤0.01% | 4577 |
|